Lin Yang

机构：Fujian Medical University, Peking University, Tianjin Medical University General Hospital, Soochow University, Ningbo No. 2 Hospital, Xi'an Medical University, Suzhou Guangji Hospital, Robotics Research (United States), Second Affiliated Hospital of Xi'an Jiaotong University, Stomatology Hospital, Second Peoples Hospital of Shaanxi Province, Fujian Provincial Cancer Hospital, Ningbo No.6 Hospital · ORCID：0000-0002-7594-3770

发表论文 513 篇 · 总被引 11376 次 · h-index 53

代表论文

• Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• Deep learning-based histomorphological subtyping and risk stratification of small cell lung cancer from hematoxylin and eosin-stained whole slide images (2025 · Genome Medicine · 被引 11)
• Integrated CRISPR/Cas12a-activated liposomal SERS amplification in microfluidic chips for ultrasensitive ampicillin detection (2025 · Biosensors and Bioelectronics · 被引 7)
• Spatial proteomic profiling reveals conserved prognostic immune microenvironment features across molecular subtypes in small cell lung cancer (2025 · Pharmacological Research · 被引 6)
• Strain-gradient-driven decoupling of thermal suppression from anisotropy in β-Ga2O3 (2026 · Acta Materialia · 被引 4)
• The burden of sleep disturbances and vasomotor symptoms on work productivity, activity impairment and healthcare resource use in perimenopausal and postmenopausal women (2025 · Maturitas · 被引 3)